Skip to main content
SpringerLink
Log in

LOH (late onset hypogonadism) oder „aging male“

LOH (late-onset hypogonadism) or the “aging male”

  • Leitthema
  • Published:
Der Urologe Aims and scope Submit manuscript

Zusammenfassung

Das Testosterondefizit des alternden Mannes (LOH, late onset hypogonadism) oder „aging male“ ist aufgrund der fehlenden Evidenz der vorliegenden Daten für Andrologen eine Herausforderung. Diese Herausforderung muss sowohl in der Grundlagenforschung als auch in der klinischen Beobachtung und Anwendung angenommen werden, damit wir über das Niveau der bestehenden Leitlinien hinaus unsere Patienten beraten und behandeln können.

Abstract

Due to lacking evidence of the data about testosterone deficiency of the aging male or LOH (late-onset hypogonadism), this subject is still a challenge for urologists, endocrinologists, and dermatologists or andrologists. This challenge faces basic research as well as clinical investigations. We have to accept responsibility for solving this challenge to better understand and better treat our patients beyond the scope of current guidelines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Behre H (2004) Testosteronmangel und die Problematik der Normwerte. Urologe A 43(9): 1082–1086

    PubMed  Google Scholar 

  2. Beutel M, Schneider H, Weidner W (2004) Symptomatik oder Befindlichkeitsstörung des alternden Mannes – welche Fragebögen stehen zur Verfügung? Urologe A 43(9): 1069–1075

    PubMed  Google Scholar 

  3. Bundesinstitut für Bevölkerungsforschung (2000) Bevölkerung: Fakten – Trends – Ursachen – Erwartungen. Schriftenreihe des BiB, Bundesinstitut für Bevölkerungsforschung, Wiesbaden

  4. Feldman H, Goldstein I, Hatzichristou D et al. (1994) Impotence and its medical and psychological correlates. Results of the Massachusetts Male Aging Study. J Urol 151: 54–61

    PubMed  Google Scholar 

  5. Feldman H, Longcope C, Derby C et al. (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87: 589–598

    Article  PubMed  Google Scholar 

  6. Haag K (1989) Philosophischer Vortrag. Haag K, Frankfurt

  7. Jockenhövel F (2003) Männlicher Hypogonadismus – aktuelle Aspekte der Androgensubstitution, 2. Aufl. Uni-Med, Bremen

  8. Kaufman J, Vermeulen A (1997) Declining gonadal function in elderly men. Baillieres Clin Endocrinol Metab 11: 289–309

    Article  PubMed  Google Scholar 

  9. Li J, Zhu J, Dou J et al. (2002) Effects of androgen supplementation therapy on partial androgen deficiency in the aging male: a preliminary study. Aging Male 5: 47–51

    PubMed  Google Scholar 

  10. Litman H, Bhasin S, Link C et al. (2006) Do circulating androgen levels vary by racial/ethnic group? Results from the Boston Area Community Health (BACH) Survey. The 5. Aging Male Congress, 2/2006

  11. Ludwig G (2000) PADAM aus andrologischer Sicht. Urologe A 39(5): 407–410

    Article  PubMed  Google Scholar 

  12. Morales A (2004) Andropause (or symptomatic late-onset hypogonadism): facts, fiction and controversies. Aging Male 7: 297–303

    Article  PubMed  Google Scholar 

  13. Morales A, Lunenfeld B (2002) Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 5(2): 74–86

    PubMed  Google Scholar 

  14. Nieschlag E, Swerdloff R, Behre H et al. (2005) Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 8: 56–58

    Article  PubMed  Google Scholar 

  15. Oettel M, Mukhopadhyay A (2004) Progesterone: the forgotten hormone in men? Aging Male 7: 236–257

    Article  PubMed  Google Scholar 

  16. Schubert M, Jockenhövel F, Brüning J (2004) Testosteron. In: Böhm M, Jockenhövel F, Weidner W (Hrsg) Männersprechstunde, Springer, Berlin Heidelberg New York, S 31–50

  17. Schubert M, Minnemann T, Hübler D et al. (2004) Intramuscular testosterone-undecanoate – pharmacokinetic aspects of a novel testosterone formulation during long term treatment of men with hypogonadism. J Clin Endocrinol Metab 89: 5429–5434

    Article  PubMed  Google Scholar 

  18. Swerdloff R, Wang C, Cunningham G et al. (2000) Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab 85: 4500–4510

    Article  PubMed  Google Scholar 

  19. Tenover L (1996) Effects of androgen supplementation in the aging male. In: Oddens B, Vermeulen A (eds) Androgens and aging male. Parthenon Publishing, New York

  20. Traish A, Kim N (2005) The physiological role of androgens in penile erection: regulation of corpus cavernosum and structure. J Sex Med 2: 759–770

    Article  PubMed  Google Scholar 

  21. Vermeulen A (2003) Diagnosis of partial androgen deficiency in the aging male. Ann Endocrin 64(2): 109–114

    Google Scholar 

  22. World Health Organization (2000) Men, ageing and health. Aging Male 3: 3–36

    Google Scholar 

  23. Yaffe K, Lui L, Zmuda J, Cauley J (2002) Sex hormones and cognitive function in older men. J Am Geriatr Soc 50: 707–712

    Article  PubMed  Google Scholar 

  24. Zitzmann M, Gromoll J, Nieschlag E (2005) The androgen receptor CAG repeat polymorphism. Andrologia 37: 216

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.

Author information

Authors and Affiliations

  1. Klinik für Urologie, Kliniken Maria Hilf GmbH, Viersener Straße 450, 41063, Mönchengladbach

    H. Sperling

  2. Evangelisches Krankenhaus, Herne

    F. Jockenhövel

  3. Krankenanstalt Rudolfstiftung, Wien, Österreich

    W. Stackl

  4. Andrologicum, München

    F.-M. Köhn

  5. Städtische Kliniken, Frankfurt-Höchst

    G. Ludwig

Authors
  1. H. Sperling
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Jockenhövel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Stackl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F.-M. Köhn
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Ludwig
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Sperling.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sperling, H., Jockenhövel, F., Stackl, W. et al. LOH (late onset hypogonadism) oder „aging male“. Urologe 45 (Suppl 4), 163–168 (2006). https://doi.org/10.1007/s00120-006-1131-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-006-1131-6

Schlüsselwörter

Keywords

Search

Navigation